Frank Torti insider trades
Open-market stock purchases and sales by Frank Torti, President and Vant Chair at Roivant Sciences Ltd, from SEC Form 4 filings since Oct 15, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | $1.5M |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd | Sold (not open market) | $1.4M |
| Apr 7, 2026 | IMVT Immunovant, Inc | Bought (not open market) | — |
| Apr 7, 2026 | IMVT Immunovant, Inc | Bought (not open market) | — |
| Mar 31, 2026 | ROIV Roivant Sciences Ltd | Sold (not open market) | $4.4M |
| Feb 23, 2026 | ROIV Roivant Sciences Ltd | Sold | $16.2M |
| Feb 23, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Feb 20, 2026 | ROIV Roivant Sciences Ltd | Sold | $27.5M |
| Feb 20, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Feb 19, 2026 | ROIV Roivant Sciences Ltd | Sold | $38.4M |
| Feb 19, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Dec 24, 2025 | ROIV Roivant Sciences Ltd | Sold (not open market) | $1.5M |
| Dec 24, 2025 | ROIV Roivant Sciences Ltd | Sold (not open market) | — |
| Dec 23, 2025 | ROIV Roivant Sciences Ltd | Bought (not open market) | $3.9M |
Companies traded
- ROIV Roivant Sciences Ltd: 3 sales, last Sep 30, 2026
- IMVT Immunovant, Inc: 1 buy, last Apr 7, 2026
- ABUS Arbutus Biopharma Corp: other filings, last May 23, 2024
- SIOX Sio Gene Therapies Inc: other filings, last Apr 15, 2021
- AXGT Axovant Gene Therapies Ltd: other filings, last Apr 15, 2020
- MYOV Myovant Sciences Ltd: other filings, last Aug 23, 2019
- UROV Urovant Sciences Ltd: other filings, last Jul 9, 2019
- AXON Axovant Sciences Ltd: other filings, last Oct 15, 2018